The role of helper and regulatory T cells in the pathogenesis of vitiligo
- 1 February 2009
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 60 (2), 256-260
- https://doi.org/10.1016/j.jaad.2008.09.048
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritidesArthritis & Rheumatism, 2008
- The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune diseaseClinical and Experimental Immunology, 2007
- Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell TiesImmunity, 2006
- Imbalance of regulatory T cells in human autoimmune diseasesImmunology, 2006
- TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T CellsImmunity, 2006
- Increased tumor necrosis factor alpha (TNF‐α) and interleukin 1 alpha (IL1‐α) levels in the lesional skin of patients with nonsegmental vitiligoInternational Journal of Dermatology, 2006
- Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokinesJournal of the American Academy of Dermatology, 2004
- Increased interleukin-6 and granulocyte–macrophage clony stimulating factor levels in the sera of patients with non-segmental vitiligoJournal of Dermatological Science, 2003
- Alterations in IL-6, IL-8, GM-CSF. TNF-α, and IFN-γ Release by Peripheral Mononuclear Cells in Patients with Active VitiligoJournal of Investigative Dermatology, 1997
- Interleukins 1α and 6 and Tumor Necrosis Factor-α Are Paracrine Inhibitors of Human Melanocyte Proliferation and MelanogenesisJournal of Investigative Dermatology, 1991